134 related articles for article (PubMed ID: 1016534)
1. Why does a tumor grow.
Ablin RJ
Allergol Immunopathol (Madr); 1976; 4(6):449-60. PubMed ID: 1016534
[No Abstract] [Full Text] [Related]
2. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
McKenzie IF; Snell GD
Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
[No Abstract] [Full Text] [Related]
3. [Immunodepressive action of the tumor].
Belokhvostov AS
Vopr Onkol; 1978; 24(3):99-106. PubMed ID: 347712
[No Abstract] [Full Text] [Related]
4. Runt disease in mice after pretreatment of the mother with tumor antigens.
Matusevich M; Piazzon I; Déroche A; Pasqualini CD
Medicina (B Aires); 1981; 41(3):321-7. PubMed ID: 7198710
[No Abstract] [Full Text] [Related]
5. Effect of syngeneic RNA pretreatment on the growth of an allogeneic mouse tumor.
Comerauer ME; Dosne Pasqualini C
Acta Physiol Lat Am; 1976; 26(2):150-3. PubMed ID: 1030178
[No Abstract] [Full Text] [Related]
6. [Why does a tumor grow?].
Dosne Pasqualini C; Laguens RP; Colmerauer ME; Segal A
Medicina (B Aires); 1974; 34(6):659-64. PubMed ID: 4617837
[No Abstract] [Full Text] [Related]
7. Second counterpoint: animal tumor models and their relevance to human tumor immunology.
Herberman RB
J Biol Response Mod; 1983; 2(3):217-26. PubMed ID: 6644338
[No Abstract] [Full Text] [Related]
8. Participation of macrophages in tumor immunity.
Tevethia SS; Zarling JM
Natl Cancer Inst Monogr; 1972 Dec; 35():279-82. PubMed ID: 4349149
[No Abstract] [Full Text] [Related]
9. Expression of various tumor-specific antigens in polyoma virus-induced tumors.
Ting CC; Lavrin DH; Takemoto KK; Ting RC; Herberman RB
Cancer Res; 1972 Jan; 32(1):1-6. PubMed ID: 4332472
[No Abstract] [Full Text] [Related]
10. [Detection of erythroblast antigen in mice in tumor cells and in leukemia by means of immunofluorescence and immunoautoradiography].
Ievleva ES; Rozinova EN; Irlin IS
Probl Gematol Pereliv Krovi; 1979 Nov; 24(11):40-3. PubMed ID: 388410
[No Abstract] [Full Text] [Related]
11. [Blood lymphocytes in cancer].
Shats VIa
Tsitologiia; 1972 Jan; 14(1):3-12. PubMed ID: 4551781
[No Abstract] [Full Text] [Related]
12. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
[No Abstract] [Full Text] [Related]
13. [Immunology of tumors].
Clerici E
Minerva Nefrol; 1983; 30(2 Suppl):13-8. PubMed ID: 6866320
[No Abstract] [Full Text] [Related]
14. Immunosuppression and oncogenic virus infections.
Hirsch MS; Black PH; Proffitt MR
Fed Proc; 1971; 30(6):1852-7. PubMed ID: 4330993
[No Abstract] [Full Text] [Related]
15. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
Lake P; Sabbadini E; Sehon AH
Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
[TBL] [Abstract][Full Text] [Related]
16. [Cytotoxic lymphocytes and anti-tumor immunity].
Cerottini JC; Brunner KT
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
[No Abstract] [Full Text] [Related]
17. Tumor polypassage at short intervals, a new method in experimental cancer.
Costăchel O; Popp I
Arch Immunol Ther Exp (Warsz); 1967; 15(5):770-80. PubMed ID: 5595078
[No Abstract] [Full Text] [Related]
18. Immune response against apparently host-compatible transplantable tumors.
Manson LA; Goldstein L; Thorn R; Palmer J
Transplant Proc; 1975 Jun; 7(2):161-4. PubMed ID: 1129841
[No Abstract] [Full Text] [Related]
19. Immune responses to soluble tumor antigens in various stages of tumor growth.
Brannen GE; Santos GW
Invest Urol; 1975 Sep; 13(2):79-84. PubMed ID: 1184342
[TBL] [Abstract][Full Text] [Related]
20. Foreign body devices permitting allogeneic tumor growth in mice.
Saal F; Colmerauer ME; Dosne Pasqualini C
Medicina (B Aires); 1972; 32(6):612-8. PubMed ID: 4679194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
